Aloj, S. and Edelhoch, H (1971). The molecular properties of human chorionic somatomammotropin. J. Biol. Chem 247, 1146-1152.[Abstract/Free Full Text]
Aubert, M. L., Bewley, T. A., Grumbach, M. M., Kaplan, S. L. and Li, C. H (1986). Structure-function studies on human growth hormone. Evidence that tertiary structure is essential for biological activity. Int. J. Pept. Protein Res 28, 45-57.[Medline]
Barrera-Salda\226a, H. A., Seeburg, P. H. and Saunders, G. F (1983). Two structurally different genes produce the same secreted human placental lactogen hormone. J. Biol. Chem 258, 3787-3793.[Abstract/Free Full Text]
Behncken, S. N., Rowlinson, S. W., Rowland, J. E., Conway-Campbell, B. L., Monks, T. A. and Waters, M. J (1997). Aspartate 171 is the major primate-specific determinant of human growth hormone. Engineering porcine growth hormone to activate the human receptor. J. Biol. Chem 272, 27077-27083.[Abstract/Free Full Text]
Bewley, T. A., Dixon, J. S. and Li, C. H (1972). Sequence comparison of human pituitary growth hormone, human chorionic somatomammotropin and ovine pituitary growth and lactogenic hormones. Int. J. Pept. Protein Res 4, 281-287.[Medline]
Castro-Mu\226ozledo, F., Marsch-Moreno, M., Beltr\207n-Langarica, A. and Kuri-Harcuch, W (1987). Commitment of adipocyte differentiation in 3T3 cells is inhibit by retinoic acid and the expression of lipogenic enzymes is modulated through cytoskeleton stabilization. Differentiation 36, 211-219.[Medline]
Chawla, R. J., Parks, J. S. and Rudman, D (1983). Structural variants of human growth hormone: biochemical, genetic and clinic aspects. Annu. Rev. Med 34, 519-547.[Medline]
Chen, W.-Y., Chen. N., Yun, J., Wagner, T. E. and Kopchick, J (1994). In vitro and in vivo studies of antagonistic effects of human growth hormone analogs. J. Biol. Chem 269, 15892-15897.[Abstract/Free Full Text]
Clarkson, R. W. E., Chen, C. M., Harrison, S., Wells, C., Muscat, G. E. O. and Waters, M. J (1995). Early responses of trans-activating factors to growth hormone in preadipocytes: differential regulation of CCAAT enhancer-binding protein-(C/EBP ) and C/EBP. Mol. Endocrinol 9, 108-120.[Abstract]
Clewell, D. B. and Helsinki, D. R (1969). Supercoiled circular DNA-protein complex in Escherichia coli: purification and induced conversion to an open circular DNA form. Proc. Nat. Acad. Sci. USA 62, 1159-1166.[Abstract/Free Full Text]
Cooke, N. E., Coit, D., Shine, J., Daxter, J. D. and Martial, J. A (1981). Human prolactin cDNA: Structural analysis and evolutionary comparisons. J. Biol. Chem 256, 4007-4016.[Abstract/Free Full Text]
Cunningham, B. C., Jhurani, P., Ng, P. and Wells, J. A (1989). Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science 243, 1330-1336.[Abstract/Free Full Text]
Cunningham, B. C., Ultsch, M., DeVos, A. M., Mulkerrin, M. G., Clauser, K. R. and Wells, J. A (1991). Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254, 821-825.[Abstract/Free Full Text]
Cunningham, B. C. and Wells, J. A (1993). Comparison of a structural and a functional epitope. J. Mol. Biol 234, 554-563.[Medline]
Dattani, M. T., Hinmarsh, P. C., Brook, C. G. D., Robinson, I., Kopchick, J. J. and Marshall, N. J (1995). G120R, a human growth hormone antagonist, shows zinc-dependent agonist and antagonist activity on Nb2 cells. J. Biol. Chem 270, 9222-9226.[Abstract/Free Full Text]
De Vos, A. M., Ultsch, M. and Kossiakoff, A. A (1992). Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255, 306-312.[Abstract/Free Full Text]
Fuh, G., Cunningham, B. C., Fukunaga, R., Nagata, S., Goeddel, D. V. and Wells, J. A (1992). Rational design of potent antagonist to the human growth hormone receptor. Science 256, 1677-1680.[Abstract/Free Full Text]
Fuh, G., Colosi, P., Wood, W. I. and Wells, J. A (1993). Mechanism-based design of prolactin receptor antagonist. J. Biol. Chem 268, 5376-5381.[Abstract/Free Full Text]
Gertler, A., Grosclaude, J., Strasburger, C. J., Nir, S. and Djiane, J (1996). Real-time kinetic measurements of the interactions between lactogenic hormones and prolactin-receptor extracellular domains from several species support the model of hormone-induced transient receptor dimerization. J. Biol. Chem 271, 24482-24491.[Abstract/Free Full Text]
Gr\207f, L. and Li, C. H (1981). Human somatotropin: covalent reconstitution of two polypeptide contiguous fragments with thrombin. Proc. Nat. Acad. Sci. USA 78, 6135-6138.[Abstract/Free Full Text]
Green, H., Morikawa, M. and Nixon, T (1985). A dual effector theory of growth-hormone action. Differentiation 29, 195-198.[Medline]
Harding, P. A., Wang, X., Okada, S., Chen, W. Y., Wam, W. and Kopchick, J. J (1996). Growth hormone (GH) and GH antagonist promote GH receptor dimerization and internalization. J. Biol. Chem 271, 6708-6712.[Abstract/Free Full Text]
Helman, D., Staten, N. R., Byatt, J., Grosclaude, J., McKinnie, R. E., Djiane, J. and Gertler, A (1997). Site-directed mutagenesis of recombinant bovine placental lactogen at lysine-73 leads to selective attenuation of its somatogenic activity. Endocrinology 138, 4069-4080.[Abstract/Free Full Text]
Hu, E., Tontonoz, P. and Spiegelman, B. M (1995). Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR2 and C/EBP. Proc. Nat. Acad. Sci. USA 92, 9856-9860.[Abstract/Free Full Text]
Ilondo, M., Damholt, A., Cunningham, B. C., Wells, J., De Meyts, P. and Shymko, R (1994). Receptor dimerization determines the effects of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes. Endocrinology 134, 2397-2403.[Abstract]
Kostyo, J. L. and Wilhelmi, A. E (1976). Conference on the structure-function relationship of pituitary growth hormone: a report. Metabolism 25, 105-124.[Medline]
Kuri-Harcuch, W. and Green, H (1977). Increasing activity of enzymes on pathway of triacylglycerol synthesis during adipose conversion of 3T3 cells. J. Biol. Chem 252, 2158-2160.[Abstract/Free Full Text]
Kuri-Harcuch W. and Green, H (1978). Adipose conversion of 3T3 cells depends on a serum factor. Proc. Nat. Acad. Sci. USA 75, 6107-6109.[Abstract/Free Full Text]
Kuri-Harcuch, W., Wise, L. S. and Green, H (1978). Interruption of the adipose conversion of 3T3 cells by biotin deficiency: differentiation without triglyceride accumulation. Cell 14, 53-59.[Medline]
Lewis, U. J., Lewis, L. J., Salem, M. A. M., Staten. N. R., Galosy, S. S., Krivi, G. G (1991). A recombinant DNA-derived modification of human growth hormone (hGH 44-191) with enhanced diabetogenic activity. Mol. Cell. Endocrinol 78, 45-54.[Medline]
Li, C. H. and Graf, L (1974). Human pituitary growth hormone: isolation and properties of two biologically active fragments from plasmin digests. Proc. Nat. Acad. Sci. USA 71, 1197-1201.[Abstract/Free Full Text]
Li, C. H. and Bewley, T. A (1976). Human pituitary growth hormone: restoration of full biological activity by noncovalent interaction of two fragments of the hormone. Proc. Nat. Acad. Sci. USA 73, 1476-1479.[Abstract/Free Full Text]
Lowman, H. B., Cunningham, B. C. and Wells, J. A (1991). Mutational analysis and protein engineering of receptor-binding determinants in human placental lactogen. J. Biol. Chem 266, 10982-10988.[Abstract/Free Full Text]
Mode, A., Tollet, P., Wellis, T., Carmignac, D. F., Clark, R. G., Chen, W.-Y., Kopchick, J. J. and Robinson, I (1996). The human growth hormone (hGH) antagonistG120RhGH does not antagonize GH in the rat, but has paradoxical agonist activity, probably via the prolactin receptor. Endocrinology 137, 447-454.[Abstract]
Mondon, C. E., Reaven, G. M., Ling,N., Lewis, U. J. and Frigeri, L. G (1988). Amino-terminal peptide of growth hormone enhances insulin action in normal rats. Endocrinology 123, 827-833.[Abstract]
Morikawa, M., Nixon, T. and Green, H (1982). Growth hormone and the adipose conversion of 3T3 cells. Cell 29, 783-789.[Medline]
Morikawa, M., Green, H. and Lewis, U. J (1984). Activity of human growth hormone and related polypeptides on the adipose conversion of 3T3 cells. Mol. Cell. Biol 4, 228-231.[Abstract/Free Full Text]
Ng, F. M. and Harcourt, J. A (1986). Stimulation of 2-deoxyglucose uptake in rat adipocytes by a human growth hormone fragment (hGH 4-15). Diabetologia 29, 882-887.[Medline]
Ng, F. M. and Rotstein, T (1988). Pancreatic effect of a hypoglycaemic fragment of human growth hormone (hGH 6-13). Diabetes Res 7, 103-108.[Medline]
Nixon, T. and Green, H (1983). Properties of growth hormone receptors in relation to the adipose conversion of 3T3 cells. J. Cell. Physiol 115, 291-296.[Medline]
Ohlsson, C., Nilsson, A., Isaksson, O. and Lindahl, A (1992). Growth hormone induces multiplication of the slowly cycling germinal cells of the rat tibial growth plate. Proc. Nat. Acad. Sci. USA 89, 9826-9830.[Abstract/Free Full Text]
Pairault, J. and Green, H (1979). A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation marker. Proc. Nat. Acad. Sci. USA 76, 5138-5142.[Abstract/Free Full Text]
Palmiter, R. D., Behringer, R. R., Quaife, C. J., Maxwell, F., Maxwell, I. H., Brinster, R. L (1987). Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 50, 435-443.[Medline]
Pe\226a, C., Poskus, E. and Paladini, A. C (1980). A relevant antigenic site in hGH localized in sequence 98-128. Mol. Immunol 17, 1487-1491.[Medline]
Ram\222rez-Sol\222s, R., Resendez-Perez, D., Alvidrez-Quihui, L. E., Rincon-Limas, D. E., Varela-Mart\222nez, R., Mart\222nez-Rodr\222guez, H. G. and Barrera-Salda\226a, H. A (1990). New vectors for the efficient expression of mammalian genes in cultured cells. Gene 87, 291-294.[Medline]
Ray, J., Okamura, H., Kelly, P. A., Liebhaber, S. A. and Cooke, N. E (1990). Alteration in the receptor binding specificity of human growth hormone by genomic exon exchange. Mol. Endocrinol 4, 101-107.
Reagan, C. R., Mills, J. B., Kostyo, J. L. and Wilhelmi, A. E (1975). Isolation and biological characterization of fragments of human growth hormone produced by digestion with plasmin. Endocrinology 96, 625-636.[Abstract]
Resendez-Perez, D. and Barrera-Salda\226a, H. A (1990). Expression studies of transfected multigene families by homologous DNA mutagenesis. Biotechniques 9, 281-286.[Medline]
Resendez-Perez, D., Ram\222rez-Sol\222s, T., Varela-Echavarr\222a, A., Mart\222nez-Rodr\222guez, H. G. and Barrera-Salda\226a, H. A (1990). Coding potential of transfected human placental lactogen genes. Nucl. Acids Res 18, 4665-4670.[Abstract/Free Full Text]
Salazar-Olivo, L. A., Castro-Mu\226ozledo, F. and Kuri-Harcuch, W (1995). A preadipose 3T3 cell variant highly sensitive to adipogenic factors and to human growth hormone. J. Cell Sci 108, 2101-2107.[Abstract]
Salem, M. A (1988). Effects of the amino-terminal portion of human growth hormone on glucose clearance and metabolism in normal, diabetic,hypophysectomized and diabetic-hypophysectomized rats. Endocrinology 123, 1565-1576.[Abstract]
Schwartz, J. and Carter-Su, C (1988). Effects of growth hormone on glucose metabolism and glucose transport in 3T3-F442A cells: Dependence on cell differentiation. Endocrinology 122, 2247-2256.[Abstract]
Silva, C. M., Weber, M. J. and Thorner, M. O (1993). Stimulation of tyrosine phosphorylation in human cells by activation of the growth hormone receptor. Endocrinology 132, 101-108.[Abstract]
Singh, R. N. P., Seavey, B. K., Lewis, L. J. and Lewis, U. J (1983). Human growth hormone peptide 1-43: isolation from pituitary glands. J. Protein Chem 2, 425-436.
Sonenberg, M., Kikutani M., Free, C. A., Nadler, A. C. and Dellacha, J. M (1968). Chemical and biological characterization of clinically active tryptic digests of bovine growth hormone. Ann. NY Acad. Sci 148, 532-558.[Medline]
Stevenson, R. W., Stebbing, N., Rudman, C. G., Williams, P. E. and Cherrington, A. D (1987). The synthetic 32-46 fragment of human growth hormone increases insulin and glucagon levels in the conscious dog. Metabolism 36, 400-404.[Medline]
Takahashi, Y., Shirono, H., Arisaka, O., Takahashi, K., Yagi, T., Koga, J., Kaji, H., Okimura, Y., Abe, H., Tanaka, T. and Chijara, K (1997). Biologically inactive growth hormone caused by an amino acid substitution. J. Clin. Invest 100, 1159-1165.[Medline]
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. and Spiegelman, B. M (1994). mPPAR2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8, 1224-1234.[Abstract/Free Full Text]
Uchida, E., Shimokawa, S., Nishida, Y., Takasu, H., Ikehara, M., Uesugi, S., Tomita, K., Morikawa, M., Hayakawa, T. and Nishikawa, S (1990). An active site of growth hormone for eliciting the differentiation of preadipose 3T3-F442A cells to adipose cells. Biochem. Biophys. Res. Commun 172, 357-363.[Medline]
Vashdi-Elberg, D., Staten, N. R., Sakal, E., Krivi, G. G. and Gertler, A (1995). N-Terminal-truncated recombinant analogs of bovine placental lactogen: Interaction with human and rat growth hormone receptors and insulin-like growth factor-I secretion mediated by somatogenic receptors in rat hepatocytes. Endocrinology 136, 1258-1266.[Abstract]
Wells, J. A. and de Vos, A. M (1996). Hematopoietic receptor complexes. Annu. Rev. Biochem 65, 609-634.[Medline]
Wise, L. S. and Green, H (1979). Participation of one isoenzyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells. J. Biol. Chem 254, 273-275.[Abstract/Free Full Text]
Yamasaki, N., Kikitani, M. and Sonenberg, M (1970). Peptides of a biologically active tryptic digest of bovine growth hormone. Biochemistry 9, 1107-1114.[Medline]
